Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

OBJECTIVE: To evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with COBRA therapy. METHODS: This economic evaluation was performed next to the open-label, randomised non-inferiority COBR...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:RMD Open
Auteurs principaux: ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2017
Sujets:
Rheumatoid Arthritis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663254/
https://ncbi.nlm.nih.gov/pubmed/29119006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000502
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires